SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Feb-23 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 13-Feb-23 | Sale | 2,790 | $9.67 | $26,966.20 | (4%) 68.35K to 65.56K | |
16-Jun-22 4:15 PM View: | Editas Medicine, Inc. (EDIT) | 15-Jun-22 | Sale | 5,145 | $10.06 | $51,744.80 | (7%) 73.49K to 68.35K | |
11-Feb-22 4:21 PM View: | Editas Medicine, Inc. (EDIT) | 10-Feb-22 | Grant | 31,709 | -- | -- | 76% 41.78K to 73.49K | |
23-Dec-21 4:10 PM View: | Editas Medicine, Inc. (EDIT) | 22-Dec-21 | Grant | 9,084 | -- | -- | 28% 32.7K to 41.78K | |
16-Jun-21 4:19 PM View: | Editas Medicine, Inc. (EDIT) | 14-Jun-21 | Grant | 32,701 | -- | -- | 100% 0 to 32.7K | |
18-Aug-20 6:15 PM View: | Applied Genetic Technologie... (AGTC) | 15-Aug-20 | Payment of Exercise | 5,723 | $5.77 | $33,021.70 | (15%) 39.0K to 33.28K | |
19-Aug-19 7:57 PM View: | Applied Genetic Technologie... (AGTC) | 15-Aug-19 | Grant | 39,000 | -- | -- | 100% 0 to 39.0K | |
18-Dec-18 7:58 PM View: | Applied Genetic Technologie... (AGTC) | 14-Dec-18 | Market Sale | 3,000 | $3.35 | $10,052.70 | (100%) 3.0K to 0 | 3% |
26-Sep-16 5:20 PM View: | Applied Genetic Technologie... (AGTC) | 22-Sep-16 | Market Purchase | 3,000 | $8.87 | $26,601.50 | 100% 0 to 3.0K | (66%) |